Related references
Note: Only part of the references are listed.Cannabis Use is Associated With Reduced 30-Day All-cause Readmission Among Hospitalized Patients With Irritable Bowel Syndrome A Nationwide Analysis
Catherine Choi et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2022)
Trends and Socioeconomic Health Outcomes of Cannabis Use Among Patients With Gastroparesis A United States Nationwide Inpatient Sample Analysis
Thomas R. McCarty et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2022)
Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents
Joel Castro et al.
PAIN (2022)
Emulsion, hydrogel and emulgel systems and novel applications in cannabinoid delivery: a review
Kelly Light et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)
Genetic variation in endocannabinoid signaling is associated with differential network-level functional connectivity in youth
Lucinda M. Sisk et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2022)
Endocannabinoid signaling of homeostatic status modulates functional connectivity in reward and salience networks
Cristina Martin-Perez et al.
PSYCHOPHARMACOLOGY (2022)
Diminished androgen levels are linked to irritable bowel syndrome and cause bowel dysfunction in mice
Daniella Rastelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing
Anne-Claire B. van Orten-Luiten et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
Ami D. Sperber et al.
GASTROENTEROLOGY (2021)
Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases
Daniel B. Maselli et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
Noelle van Egmond et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia
Giovanni Sarnelli et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
The gut microbiome, endocannabinoids and metabolic disorders
Fabio Arturo Iannotti et al.
JOURNAL OF ENDOCRINOLOGY (2021)
Local immune response to food antigens drives meal-induced abdominal pain
Javier Aguilera-Lizarraga et al.
NATURE (2021)
Sex differences and the endocannabinoid system in pain
Henry L. Blanton et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2021)
Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities
Mireille Alhouayek et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2021)
The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man
Saoirse Elizabeth O'Sullivan et al.
MOLECULES (2021)
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders
Chris Eijsbouts et al.
NATURE GENETICS (2021)
Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet
Isabella Gigante et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Analgesic Potential of Terpenes Derived from Cannabis sativa
Erika Liktor-Busa et al.
PHARMACOLOGICAL REVIEWS (2021)
Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders
Malvika Kaul et al.
NEUROTHERAPEUTICS (2021)
Impact of Diet on Symptoms of the Irritable Bowel Syndrome
Robin Spiller
NUTRIENTS (2021)
Amygdala microglia modify neuronal plasticity via complement C1q/C3-CR3 signaling and contribute to visceral pain in a rat model
Tian Yuan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)
A Proteomic View of Cellular and Molecular Effects of Cannabis
Morteza Abyadeh et al.
BIOMOLECULES (2021)
Endocannabinoid system mediates the association between gut-microbial diversity and anhedonia/amotivation in a general population cohort
Amedeo Minichino et al.
MOLECULAR PSYCHIATRY (2021)
Subcellular specificity of cannabinoid effects in striatonigral circuits
Edgar Soria-Gomez et al.
NEURON (2021)
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
Marie D'hooghe et al.
BMC NEUROLOGY (2021)
Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils
Slavko Komarnytsky et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Development of a novel cannabinoid-loaded microemulsion towards an improved stability and transdermal delivery
Chulhun Park et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
A Phase-2 Pilot Study of a Therapeutic Combination of Δ9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette's Syndrome
Michael H. Bloch et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2021)
The cannabinoid system and microglia in health and disease
Samuel S. Duffy et al.
NEUROPHARMACOLOGY (2021)
Approved cannabinoids for medical purposes-Comparative systematic review and meta-analysis for sleep and appetite
Rainer Spanagel et al.
NEUROPHARMACOLOGY (2021)
The gastrointestinal tract in hunger and satiety signalling
Jan Tack et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)
Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis
Sage E. Foley et al.
MICROBIOME (2021)
Macrophage as a Peripheral Pain Regulator
Risa Domoto et al.
CELLS (2021)
Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting
Erin M. Rock et al.
CANNABIS AND CANNABINOID RESEARCH (2021)
A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures
Martin J. Brodie et al.
CANNABIS AND CANNABINOID RESEARCH (2021)
Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States
Rikinkumar S. Patel et al.
SUBSTANCE USE & MISUSE (2020)
Beyond THC and Endocannabinoids
Pal Pacher et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling[S]
Claudia Manca et al.
JOURNAL OF LIPID RESEARCH (2020)
Biphasic effects of methanandamide on murine gastric vagal afferent mechanosensitivity
Stewart Christie et al.
JOURNAL OF PHYSIOLOGY-LONDON (2020)
Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
Tian Hua et al.
CELL (2020)
Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy
Samiksha Pandey et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2020)
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
Mohammad Zakir Hossain et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Neuronal programming by microbiota regulates intestinal physiology
Yuuki Obata et al.
NATURE (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala
Farhana Yasmin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics
Gaurav Bedse et al.
BIOLOGICAL PSYCHIATRY (2020)
Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease
Jonathan Gotfried et al.
GASTROENTEROLOGY (2020)
Intestinal Bacteria Maintain Adult Enteric Nervous System and Nitrergic Neurons via Toll-like Receptor 2-induced Neurogenesis in Mice
Shadi S. Yarandi et al.
GASTROENTEROLOGY (2020)
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Vicente Martinez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Global burden of irritable bowel syndrome: trends, predictions and risk factors
Christopher J. Black et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
P. Grimison et al.
ANNALS OF ONCOLOGY (2020)
Alterations of brain endocannabinoidome signaling in germ-free mice
Claudia Manca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
RNA Sensing by Gut Piezo1 Is Essential for Systemic Serotonin Synthesis
Erika Sugisawa et al.
CELL (2020)
Cannabis and the Gastrointestinal Tract
Lawrence Cohen et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2020)
Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens
Melissa Ellermann et al.
CELL (2020)
The Human and Mouse Enteric Nervous System at Single-Cell Resolution
Eugene Drokhlyansky et al.
CELL (2020)
Glucose metabolism links astroglial mitochondria to cannabinoid effects
Daniel Jimenez-Blasco et al.
NATURE (2020)
Endocannabinoid-Epigenetic Cross-Talk: A Bridge toward Stress Coping
Francesco Rusconi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use
Jose Antonio Uranga et al.
MOLECULES (2020)
Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat
Sophie Castonguay-Paradis et al.
SCIENTIFIC REPORTS (2020)
Enteric Glia Modulate Macrophage Phenotype and Visceral Sensitivity following Inflammation
Vladimir Grubisic et al.
CELL REPORTS (2020)
Epigenetic Mechanisms in Irritable Bowel Syndrome
Swapna Mahurkar-Joshi et al.
FRONTIERS IN PSYCHIATRY (2020)
Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders
Paul Enck et al.
FRONTIERS IN PSYCHIATRY (2020)
Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system
Gregoire Chevalier et al.
NATURE COMMUNICATIONS (2020)
Mgll Knockout Mouse Resistance to Diet-Induced Dysmetabolism Is Associated with Altered Gut Microbiota
Niokhor Dione et al.
CELLS (2020)
High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
Mohamed G. Shiha et al.
ECLINICALMEDICINE (2020)
Colonization with the commensal fungus Candida albicans perturbs the gut-brain axis through dysregulation of endocannabinoid signaling
Laura Markey et al.
PSYCHONEUROENDOCRINOLOGY (2020)
Neurobiology of cannabinoid receptor signaling
Beat Lutz
DIALOGUES IN CLINICAL NEUROSCIENCE (2020)
Inhibition of Microglial Activation in the Amygdala Reverses Stress-Induced Abdominal Pain in the Male Rat
Tian Yuan et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats
Martin A. Sticht et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis
Adeyinka C. Adejumo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Safety and efficacy of olorinab, a peripherally restricted, highly-selective, cannabinoid receptor 2 agonist in a phase 2A study in chronic abdominal pain associated with Crohn's disease
P. Higgins et al.
JOURNAL OF CROHNS & COLITIS (2019)
Activation of cannabinoid 2 receptor relieves colonic hypermotility in a rat model of irritable bowel syndrome
Mengjuan Lin et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis
Amandine Everard et al.
NATURE COMMUNICATIONS (2019)
Effect of acute Δ9-tetrahydrocannabinol administration on subjective and metabolic hormone responses to food stimuli and food intake in healthy humans: a randomized, placebo-controlled study
Nathalie Weltens et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)
Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome
Magnus Simren et al.
GASTROENTEROLOGY (2019)
Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review
Rapat Pittayanon et al.
GASTROENTEROLOGY (2019)
Su1930 – Safety and Efficacy of Olorinab, a Peripherally Restricted, Highly Selective, Cannabinoid Receptor 2 Agonist in a Phase 2A Study in Chronic Abdominal Pain Associated with Crohn’s Disease
Bruce Yacyshyn et al.
GASTROENTEROLOGY (2019)
Role of estrogen and stress on the brain-gut axis
Yanyan Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
Zinah Zamil Al-Ghezi et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
μ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients
Giovanni Dothel et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Acute and short-term administrations of delta-9-tetrahydrocannabinol modulate major gut metabolomic regulatory pathways in C57BL/6 mice
Megha Oza et al.
SCIENTIFIC REPORTS (2019)
Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure
William T. Booth et al.
MOLECULES (2019)
Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
Vincenzo Di Marzo et al.
NUTRIENTS (2019)
Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li et al.
CELL (2019)
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar et al.
CELL (2019)
The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications
Vadim Osadchiy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Chloe J. Jordan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
Stefania Petrosino et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Sex differences in measures of central sensitization and pain sensitivity to experimental sleep disruption: implications for sex differences in chronic pain
Michael T. Smith et al.
SLEEP (2019)
Prevalence and impact of self-reported irritable bowel symptoms in the general population
K. Van den Houte et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)
Cannabinoid Use in Patients With Gastroparesis and Related Disorders: Prevalence and Benefit
Asad Jehangir et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice
Sebastien Lacroix et al.
MSYSTEMS (2019)
Insights into the role of cannabis in the management of inflammatory bowel disease
Sherman Picardo et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Pharmacogenetics of Cannabinoids
Szymon Hryhorowicz et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2018)
Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts
Magnus Simren et al.
GUT (2018)
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice
F. Guida et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America
Ran Abuhasira et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut - Brain Interaction): A Rome Foundation Working Team Report
Douglas A. Drossman et al.
GASTROENTEROLOGY (2018)
Contribution of membrane receptor signalling to chronic visceral pain
Mahsa Sadeghi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
New treatments and therapeutic targets for IBS and other functional bowel disorders
Magnus Simren et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans
M. Camilleri
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Chronic exposure to insufficient sleep alters processes of pain habituation and sensitization
Norah S. Simpson et al.
PAIN (2018)
Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses
Samir Haj-Dahmane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome
Nestor N. Jimenez-Vargas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Mechanisms of Stress-induced Visceral Pain
Beverley Greenwood-Van Meerveld et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms
Marcella Pesce et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome
Maciej Salaga et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis
Rose L. Szabady et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2018)
Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety
Thomas Larrieu et al.
FRONTIERS IN PHYSIOLOGY (2018)
Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases
Roberto Russo et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria
Elizabeth A. Kennedy et al.
FRONTIERS IN PHYSIOLOGY (2018)
Differential modulation of voltage-gated sodium channels by nerve growth factor in three major subsets of TrkA-expressing nociceptors
Irina Schaefer et al.
MOLECULAR PAIN (2018)
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
Stefania Petrosino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS
J. Tack et al.
GUT (2017)
Sleep disturbances in irritable bowel syndrome: a systematic review
Q. Tu et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice
Molly S. Crowe et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
The role of CB1 in intestinal permeability and inflammation
Mustafa A. Karwad et al.
FASEB JOURNAL (2017)
Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn's Disease
Kristina L. Leinwand et al.
JOURNAL OF CROHNS & COLITIS (2017)
Granulocyte-colony-stimulating factor (G-CSF) signaling in spinal microglia drives visceral sensitization following colitis
Lilian Basso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
*Endocannabinoid system acts as a regulator of immune homeostasis in the gut
Nandini Acharya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Kimberly A. Babson et al.
CURRENT PSYCHIATRY REPORTS (2017)
Functional and Molecular Characterization of Mechanoinsensitive Silent'' Nociceptors
Vincenzo Prato et al.
CELL REPORTS (2017)
Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity
Pegah Mehrpouya-Bahrami et al.
SCIENTIFIC REPORTS (2017)
Irritable bowel syndrome: a gut microbiota-related disorder?
Yogesh Bhattarai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome
C. Cremon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Endocannabinoids - at the crossroads between the gut microbiota and host metabolism
Patrice D. Cani et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Activation of corticotropin-releasing factor neurons and microglia in paraventricular nucleus precipitates visceral hypersensitivity induced by colorectal distension in rats
Gongliang Zhang et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
Linda Gabrielsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
The Role of the Endocannabinoid System in the Brain-Gut Axis
Keith A. Sharkey et al.
GASTROENTEROLOGY (2016)
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
Douglas A. Drossman
GASTROENTEROLOGY (2016)
Estrogen-dependent visceral hypersensitivity following stress in rats: An fMRI study
Catherine S. Hubbard et al.
MOLECULAR PAIN (2016)
Hippocampal microglial activation and glucocorticoid receptor down-regulation precipitate visceral hypersensitivity induced by colorectal distension in rats
Gongliang Zhang et al.
NEUROPHARMACOLOGY (2016)
Irritable bowel syndrome
Paul Enck et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Endocannabinoids in the Gut
Nicholas V. DiPatrizio
CANNABIS AND CANNABINOID RESEARCH (2016)
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial
Geke A. H. van den Elsen et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways
Nicholas V. DiPatrizio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2015)
Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome
Yasuhiro Iwata et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic -opioid receptor sensitivity
U. Taschler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation
M. Bashashati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner
C. M. Keenan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells
Christopher S. Reigstad et al.
FASEB JOURNAL (2015)
Epigenetic Regulation of Genes That Modulate Chronic Stress-Induced Visceral Pain in the Peripheral Nervous System
Shuangsong Hong et al.
GASTROENTEROLOGY (2015)
Nerve Fiber Outgrowth Is Increased in the Intestinal Mucosa of Patients With Irritable Bowel Syndrome
Giovanni Dothel et al.
GASTROENTEROLOGY (2015)
Intestinal lipid-derived signals that sense dietary fat
Nicholas V. DiPatrizio et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Mechanisms of stress in the brain
Bruce S. McEwen et al.
NATURE NEUROSCIENCE (2015)
Towards a systems view of IBS
Emeran A. Mayer et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders
H. Paula et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2015)
Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [18F]MK-9470 PET Study
Huynh Giao Ly et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol
Nina L. Cluny et al.
PLOS ONE (2015)
Self-Medication of Somatic and Psychiatric Conditions Using Botanical Marijuana
Lawrence A. Osborn et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2015)
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice
M. Aguilera et al.
GUT MICROBES (2015)
Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract
Keith A. Sharkey et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2014)
Classical endocannabinoid-like compounds and their regulation by nutrients
Karen Kleberg et al.
BIOFACTORS (2014)
Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels
Raffaele Capasso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system
Keith A. Sharkey et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome
Jonna Jalanka-Tuovinen et al.
GUT (2014)
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
Giuseppe Esposito et al.
GUT (2014)
Treatment of abdominal pain in irritable bowel syndrome
Tim Vanuytsel et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Decreased enteric fatty acid amide hydrolase activity is associated with colonic inertia in slow transit constipation
Shu-Cheng Zhang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome
Yingjie Jiang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
FAAH selectively influences placebo effects
M. Pecina et al.
MOLECULAR PSYCHIATRY (2014)
Neuroplasticity and dysfunction after gastrointestinal inflammation
Stuart M. Brierley et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides
J. Fichna et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
Jakub Fichna et al.
PLOS ONE (2014)
Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat
Harald S. Hansen
PHARMACOLOGICAL RESEARCH (2014)
Sex hormones in the modulation of irritable bowel syndrome
Agata Mulak et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Toll-Like Receptor 2 Regulates Intestinal Inflammation by Controlling Integrity of the Enteric Nervous System
Paola Brun et al.
GASTROENTEROLOGY (2013)
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Magnus Simren et al.
GUT (2013)
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Sangdon Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Sexually Dimorphic Effects of Unpredictable Early Life Adversity on Visceral Pain Behavior in a Rodent Model
Aaron Chaloner et al.
JOURNAL OF PAIN (2013)
Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice
M. Aguilera et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice
J. Fichna et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study
Jakub Fichna et al.
PLOS ONE (2013)
Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress
L. Tran et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses
Matthew N. Hill et al.
BIOLOGY OF MOOD & ANXIETY DISORDERS (2013)
Chemical Probes of Endocannabinoid Metabolism
Jacqueline L. Blankman et al.
PHARMACOLOGICAL REVIEWS (2013)
Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study
K. Tillisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Colonic Transit Time and IBS Symptoms: What's the Link
Hans Tornblom et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice
M. Bashashati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
A. Alhamoruni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Association Between Early Adverse Life Events and Irritable Bowel Syndrome
Kara Bradford et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Gut Microbial Products Regulate Murine Gastrointestinal Motility via Toll-Like Receptor 4 Signaling
Mallappa Anitha et al.
GASTROENTEROLOGY (2012)
Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know
Bradley E. Alger
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling
I. M. Hons et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
B. S. Wong et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo et al.
NEURON (2012)
Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome
S. Zakko et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Effect of rimonabant on oesophageal motor function in man
E. Scarpellini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells
Giuseppina Cantarella et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor
Thi Ai Diep et al.
FASEB JOURNAL (2011)
Corticosterone Mediates Reciprocal Changes in CB 1 and TRPV1 Receptors in Primary Sensory Neurons in the Chronically Stressed Rat
Shuangsong Hong et al.
GASTROENTEROLOGY (2011)
Cathepsin S Is Activated During Colitis and Causes Visceral Hyperalgesia by a PAR2-Dependent Mechanism in Mice
Fiore Cattaruzza et al.
GASTROENTEROLOGY (2011)
Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
Banny S. Wong et al.
GASTROENTEROLOGY (2011)
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors
Fabrizio Benedetti et al.
NATURE MEDICINE (2011)
The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients
T. K. Klooker et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
A. Alhamoruni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The endocannabinoid system links gut microbiota to adipogenesis
Giulio G. Muccioli et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice
M. A. Storr et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
The Role of Peripheral Cannabinoid Receptors Type 1 in Rats With Visceral Hypersensitivity Induced by Chronic Restraint Stress
Lei Shen et al.
Journal of Neurogastroenterology and Motility (2010)
Small Intestinal Cannabinoid Receptor Changes Following a Single Colonic Insult with Oil of Mustard in Mice
Edward S. Kimball et al.
Frontiers in Pharmacology (2010)
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
Fabricio A. Moreira et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat
S. Hong et al.
GUT (2009)
Activation of the Cannabinoid 2 Receptor (CB2) Protects Against Experimental Colitis
Martin A. Storr et al.
INFLAMMATORY BOWEL DISEASES (2009)
CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents
Mikael Brusberg et al.
JOURNAL OF NEUROSCIENCE (2009)
Cannabinoid receptor 1 signalling dampens activity and mitochondrial transport in networks of enteric neurones
W. Boesmans et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity
Carlos E. Leite et al.
PHARMACOLOGICAL REPORTS (2009)
Identification of intracellular carriers for the endocannabinoid anandamide
Martin Kaczocha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome
A. W. Mangel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Randomized, Double-Blind, Placebo-Controlled Trial of the 5-HT1A Receptor Antagonist AZD7371 Tartrate Monohydrate (Robalzotan Tartrate Monohydrate) in Patients With Irritable Bowel Syndrome
Douglas A. Drossman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation
Michael Camilleri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats
Marnie Duncan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
M. Naguib et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
A. Akbar et al.
GUT (2008)
Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity
Akira Kikuchi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Dysregulation of peripheral endocannabinoid levels in hyperglycernia and obesity: Effect of high fat diets
Isabel Matias et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome
M. A. Storr et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats
Fabiola Voznika Merriam et al.
NEUROSCIENCE LETTERS (2008)
The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors
Barbara Costa et al.
PAIN (2008)
Efficacy of on-demand asimadoline, a peripheral k-opioid agonist, in females with irritable bowel syndrome
Lawrence A. Szarka et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Altered rectal perception in irritable bowel syndrome is associated with symptom severity
Iris Posserud et al.
GASTROENTEROLOGY (2007)
Activation of the cannabinoid 2 (CB2) receptor inhibits murine mesenteric afferent nerve activity
K. Hillsley et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Effect of the NK3 receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans
L. A. Houghton et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study
Tuba Esfandyari et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome
Giovanni Barbara et al.
GASTROENTEROLOGY (2007)
Mechanisms of hypersensitivity in IBS and functional disorders
F. Azpiroz et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Christel Rousseaux et al.
NATURE MEDICINE (2007)
Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats
M. Sanson et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Postinfectious irritable bowel syndrome - A meta-analysis
Heather A. Halvorson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Cannabinoid tolerance and dependence:: A review of studies in laboratory animals
S González et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
G Barbara et al.
GASTROENTEROLOGY (2004)
Effect of asimadoline, a κ opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome
M Delvaux et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves
WK MacNaughton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Sex-related differences in IBS patients: Central processing of visceral stimuli
BD Naliboff et al.
GASTROENTEROLOGY (2003)
Visceral hypersensitivity
H Mertz
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection
E Grigorenko et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2002)
Endovanilloid signaling in pain
V Di Marzo et al.
CURRENT OPINION IN NEUROBIOLOGY (2002)
Hypersensitivity in functional gastrointestinal disorders
F Azpiroz
GUT (2002)
Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome
M Delvaux
GUT (2002)
Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB1 and CB2-like receptors
WP Farquhar-Smith et al.
PAIN (2002)
A double blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectosigmoid distension in IBS patients.
OY Lee et al.
GASTROENTEROLOGY (2000)
Share Paper
